Radiation therapy regulates TCF-1 to maintain CD8+T cell stemness and promotes anti-tumor immunotherapy

被引:9
|
作者
Wang, Bin [1 ]
Hu, Jing [1 ]
Zhang, Jian [2 ]
Zhao, Lina [1 ]
机构
[1] Air Force Med Univ, Xijing Hosp, Dept Radiat Oncol, 15 West Changle Rd, Xian 710032, Peoples R China
[2] Air Force Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China
关键词
Radiotherapy; TCF-1; Stem CD8+T; cGAS; STING; TME; CD8(+) T-CELLS; RADIOTHERAPY; MICROENVIRONMENT; IMMUNITY; TRIAL;
D O I
10.1016/j.intimp.2022.108646
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Radiotherapy is a very effective cancer treatment, mainly through inducing DNA damage of cancer cells. Meanwhile, there is evidence that irradiation can also mobilize tumor-specific immunity, and recent investigations demonstrate that the efficiency of local high-dose radiotherapy is attributable to the presence of CD8+T cells. Here, we observed that high-dose radiation remarkably increased the enrichment of stem cell-like CD8+T cells. Moreover, cGAS/STING signaling augmented stem cell-like CD8+T cells and T stem-like central memory CD8+T cells in a mice tumor model after radiation. These findings raise our understanding of stem celllike CD8+T cells after radiation stimulation and improve radiation therapy by driving the cGAS/STING signaling pathway for cancer multimodality therapy.
引用
收藏
页数:6
相关论文
共 46 条
  • [1] Tumor immunogenicity dictates reliance on TCF1 in CD8+T cells for response to immunotherapy
    Escobar, Giulia
    Tooley, Katherine
    Oliveras, Joan Pages
    Huang, Linglin
    Cheng, Hanning
    Bookstaver, Michelle L.
    Edwards, Camilla
    Froimchuk, Eugene
    Xue, Chang
    Mangani, Davide
    Krishnan, Rajesh K.
    Hazel, Natanael
    Rutigliani, Carola
    Jewell, Christopher M.
    Biasco, Luca
    Anderson, Ana C.
    CANCER CELL, 2023, 41 (09) : 1662 - +
  • [2] Glycolysis inhibition induces anti-tumor central memory CD8+T cell differentiation upon combination with microwave ablation therapy
    Tang, Xinyu
    Mao, Xinrui
    Ling, Peiwen
    Yu, Muxin
    Pan, Hua
    Wang, Jiaming
    Liu, Mingduo
    Pan, Hong
    Qiu, Wen
    Che, Nan
    Zhang, Kai
    Bao, Feifan
    Peng, Hongwei
    Ding, Qiang
    Wang, Shui
    Zhou, Wenbin
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [3] Intrinsic STING of CD8+T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects
    Xu, Qiuli
    Hua, Xin
    Li, Bingbing
    Jiang, Bei
    Jin, Jiajia
    Wu, Ranpu
    Gu, Yanli
    Xu, Hao
    Cheng, Qinpei
    Zhu, Suhua
    Zhang, Fang
    Lv, Tangfeng
    Song, Yong
    CELL COMMUNICATION AND SIGNALING, 2025, 23 (01)
  • [4] IL-33-ILC2 axis promotes anti-tumor CD8+T cell responses via OX40 signaling
    Okuyama, Yuko
    Okajima, Akira
    Sakamoto, Nao
    Hashimoto, Ayaka
    Tanabe, Ryuto
    Kawajiri, Akihisa
    Kawabe, Takeshi
    Ishii, Naoto
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 637 : 9 - 16
  • [5] Mixed radiation with different doses induces CCL17 to recruit CD8+T cell to exert anti-tumor effects in non-small cell lung cancer
    Huang, Liuying
    Wang, Duo
    Xu, Muchen
    Qian, Danqi
    Cao, Yulin
    Wu, Xiaohan
    Ming, Liang
    Tang, Junhui
    Huang, Zhaohui
    Yin, Yuan
    Zhou, Leyuan
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [6] Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells
    Yang, Biaolong
    Deng, Biaolong
    Jiao, Xiao-Dong
    Qin, Bao-Dong
    Lu, Yi
    Zhang, Weiqi
    Guo, Yixian
    Chen, Shiqi
    Li, Dan
    Li, Bin
    Zang, Yuan-Sheng
    CELLULAR ONCOLOGY, 2022, 45 (06) : 1297 - 1309
  • [7] A Novel TrxR1 Inhibitor Regulates NK and CD8+T Cell Infiltration and Cytotoxicity, Enhancing the Efficacy of Anti-PD-1 Immunotherapy against Hepatocarcinoma
    Su, Xiaoxia
    Yin, Hanwei
    Bai, Man
    Liu, Jiayi
    Liu, Runyu
    Zeng, Huihui
    Wen, Jinhua
    JOURNAL OF IMMUNOLOGY, 2023, 210 (05): : 681 - 695
  • [8] A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity
    Watkins-Schulz, Rebekah
    Tiet, Pamela
    Gallovic, Matthew D.
    Junkins, Robert D.
    Batty, Cole
    Bachelder, Eric M.
    Ainslie, Kristy M.
    Ting, Jenny P. Y.
    BIOMATERIALS, 2019, 205 : 94 - 105
  • [9] Elevated glutamate impedes anti-HIV-1 CD8+T cell responses in HIV-1-infected individuals on antiretroviral therapy
    Wang, You-Yuan
    Zhen, Cheng
    Hu, Wei
    Huang, Hui-Huang
    Li, Yan-Jun
    Zhou, Ming-Ju
    Li, Jing
    Fu, Yu-Long
    Zhang, Peng
    Li, Xiao-Yu
    Yang, Tao
    Song, Jin-Wen
    Fan, Xing
    Zou, Jun
    Meng, Si-Run
    Qin, Ya-Qin
    Jiao, Yan-Mei
    Xu, Ruonan
    Zhang, Ji-Yuan
    Zhou, Chun-Bao
    Yuan, Jin-Hong
    Huang, Lei
    Shi, Ming
    Cheng, Liang
    Wang, Fu-Sheng
    Zhang, Chao
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [10] Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
    Sivick, Kelsey E.
    Desbien, Anthony L.
    Glickman, Laura Hix
    Reiner, Gabrielle L.
    Corrales, Leticia
    Surh, Natalie H.
    Hudson, Thomas E.
    Vu, Uyen T.
    Francica, Brian J.
    Banda, Tamara
    Katibah, George E.
    Kanne, David B.
    Leong, Justin J.
    Metchette, Ken
    Bruml, Jacob R.
    Ndubaku, Chudi O.
    McKenna, Jeffrey M.
    Feng, Yan
    Zheng, Lianxing
    Bender, Steven L.
    Cho, Charles Y.
    Leong, Meredith L.
    van Elsas, Andrea
    Dubensky, Thomas W., Jr.
    McWhirter, Sarah M.
    CELL REPORTS, 2018, 25 (11): : 3074 - +